RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 110 - per page Next page
Order by
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
APR and the leading pharmaceutical company in Turkey Abdi Ibrahim have entered into an exclusive license agreement for the promotion, distribution and marketing of Ondansetron Rapidfilm® in Turkey; terms of the deal were not disclosed. More
The International Contract Service Event (“ICSE”), taking place in Madrid from 9th until 11th October 2012, is co-located with the “CPhI Worldwide” – the biggest international fair for the pharmaceutical industry. More
APR Applied Pharma Research s.a. opens US office in Charlotte, North Carolina More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
APR and Labtec announce the successful completion of the Pivotal Bioequivalence study for Ondansetron RapidFilm™ More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
tesa AG, based in Hamburg, has acquired Labtec Gesellschaft für technologische Forschung und Entwicklung mbH More
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
Displaying 1..10 of 110 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2014 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us